Stay updated with breaking news from Hawthorne Cloud. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Complete clinical trials solution company, Hawthorne Effect, announced today (October 10) announced it had successfully recruited more than 1,000 patients in 48 states plus Hawaii for a study to qualify the prevalence of valvular heart disease (VHD).
The study marks a new standard for inclusive medicine with recruitment for target demographics reaching over 3x the national average
Hawthorne Effect, a solution for decentralizing clinical trials, announced it has raised $20M in Series A funding led by Northpond Ventures
Northpond Ventures, SignalFire and P5 Health Ventures have helped San Francisco-based clinical trial software firm Hawthorne Effect complete a $20 million first formal funding round.
The round was led by Northpond Ventures, with participation from SignalFire and P5 Health Ventures. The company intends to use the funds to accelerate growth and help scale operations. Led by Jodi Akin, CEO and founder, Hawthorne Effect provides a solution for decentralizing clinical trials to alleviate key issues related to patient recruitment and retention via its tech-driven platform and expansive network of medical professionals. The company’s tech-driven platform, the Hawthorne Cloud, works with highly trained medical professionals, called Hawthorne Heroes, to deliver complete assess...